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Abstract
Introduction Esophagectomy for cancer can be performed
in a two-stage procedure with an intrathoracic anastomosis:
the Ivor Lewis esophagectomy. A growing incidence of
distal and gastroesophageal junction adenocarcinomas and
increasing use of minimally invasive techniques have
prompted interest in this procedure. The aim of this study
was to assess short-term results of minimally invasive Ivor
Lewis esophagectomy (MIE-IL).
Methods A retrospective cohort study was performed from
June 2007 until September 2014, including patients that
underwent MIE-IL for distal esophageal and gastroesophageal
junction cancer in six different hospitals in the Netherlands
and Spain. Data were collected with regard to operative
techniques, pathology and postoperative complications.
Results In total, 282 patients underwent MIE-IL, of which
90.2 % received neoadjuvant therapy. Anastomotic leakage
was observed in 43 patients (15.2 %), of whom 13 patients
(4.6 %) had empyema, necessitating thoracotomy for
decortication. With an aggressive treatment of complica-
tions, the 30-day and in-hospital mortality rate was 2.1 %.
An R0-resection was obtained in 92.5 % of the patients.
After neoadjuvant therapy, 20.1 % of patients had a com-
plete response.
Conclusions Minimally invasive Ivor Lewis esophagec-
tomy for distal esophageal and gastroesophageal junction
adenocarcinomas is an upcoming approach for reducing
morbidity caused by laparotomy and thoracotomy. Anas-
tomotic leakage rate is still high possibly due to technical
diversity of anastomotic techniques, and a high percentage
of patients treated by neoadjuvant chemoradiotherapy. An
aggressive approach to complications leads to a low mor-
tality of 2.1 %. Further improvement and standardization
in the anastomotic technique are needed in order to perform
a safe intrathoracic anastomosis.
Keywords Esophageal cancer  Esophagectomy 
Minimally invasive  Ivor Lewis  Intrathoracic
anastomosis
In 1946, a standardized approach to esophageal resection
for carcinoma of the middle third of the esophagus was
introduced by Ivor Lewis [1]. This approach involved a
two-stage procedure that included a laparotomy with
lymphadenectomy of the celiac trunk and formation of a
gastric conduit and, 1–2 weeks later, a right thoracotomy
with esophageal resection, peri-esophageal and subcarinal
lymphadenectomy followed by intrathoracic anastomosis.
Risk of anastomotic leakage in the thorax with its potential
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fatal sequelae—such as empyema—resulted in the devel-
opment of the three-stage approach by McKeown, with a
cervical anastomosis [2]. In case of leakage, a cervical
fistula remained a manageable complication [3]. While
randomized evidence is limited, comparative studies sug-
gest that cervical anastomosis is associated with less seri-
ous complications, but with more anastomotic leakage,
stenosis and recurrent laryngeal nerve injuries [4]. This
cervical morbidity in combination with the increased
incidence of distal esophageal and gastroesophageal junc-
tion adenocarcinomas and lower postoperative morbidity
after minimally invasive esophagectomy (MIE) has
induced renewed interest in the two-stage procedure with
an intrathoracic anastomosis [5].
In recent years, two important developments have been
introduced in esophageal surgery, i.e., the systematic use of
neoadjuvant treatment (chemotherapy or chemoradiation)
and the implementation of minimally invasive esophagec-
tomy (MIE) [5, 6]. Neoadjuvant treatment significantly
increases 5-year survival of patients with esophageal can-
cer in both squamous cell and adenocarcinomas [6]. In
addition, minimally invasive esophagectomy is increas-
ingly being implemented in order to reduce postoperative
respiratory complications and enhance the quality of life by
avoiding a right thoracotomy and laparotomy [7–11].
Aim of this study was to assess and describe the pooled
results of six European institutions performing a total
minimally invasive Ivor Lewis esophagectomy (MIE-IL)
with respect to technique and the resulting short-term
postoperative outcomes such as morbidity and mortality
and radicality of resection.
Materials and methods
A retrospective cohort study was performed of 282 con-
secutive patients, who underwent a total MIE-IL for distal
esophageal cancer (n = 160) and gastroesophageal junc-
tion cancer (n = 122 patients) since the introduction of this
approach in June 2007 [12]. Patients originated from Gir-
ona, Spain and five centers in the Netherlands (VU
University medical center and Academic Medical Center,
Amsterdam; Canisius Wilhelmina hospital in Nijmegen,
Catharina hospital in Eindhoven and Reinier de Graaf
hospital in Delft). Data were recorded from 2007 in one
center in Girona. In two centers in the Netherlands, data
were recorded from 2010 and in three other Dutch centers
data were recorded from 2012.
All hospitals performed at least over 20 esophagec-
tomies per year. Two hospitals were academic hospitals,
being the VU University medical center and Academic
Medical Center, both located in Amsterdam. The other
participating hospitals are all teaching hospitals.
A database was constructed with preoperative, intraop-
erative and postoperative data of these patients. The indices
used were age, gender, type and location of the tumor,
preoperative assessment, administration of neoadjuvant
therapy, operative technique (thoracoscopic approach in
prone position or left lateral decubitus position), anasto-
motic technique, conversions, (y)pTNM, R0 resections,
circumferential resection margins, lymph node yield,
postoperative complications, duration of hospital stay,
intensive care (IC) stay and 30-day and in-hospital
mortality.
Statistical analysis
Continuous data were described using mean and standard
deviation or median and interquartile range as appropriate
for normal and non-normal distributed data. Analysis was
performed with Student’s T test for two samples or
ANOVA with post hoc analysis for k samples for normal
distributions, and for non-normal distributions, the Mann–
Whitney U test was applied or the Kruskal–Wallis test for
k samples. For dichotomous and categorical data, fre-
quencies were displayed. Analysis was performed with
Chi-square and regression techniques.
Definitions
Anastomotic leakage was defined as a full-thickness defect
involving the esophagus, anastomosis or the gastric conduit
and graded according to severity, in concordance with the
report on standardization of data collections for compli-
cations associated with esophagectomy [13]. A grade I
anastomotic leak concerned patients with a local defect,
which did not require invasive therapy. A grade II anas-
tomotic leak concerned those patients requiring interven-
tional, but not surgical therapy (i.e., percutaneous drainage,
placement of an endoscopic stent). A grade III anastomotic
leak without thoracic empyema concerns those patients
requiring surgical treatment such as thoracoscopic
debridement, mediastinal drainage and placement of a
stent, and grade IV leakage concerns established thoracic
empyema requiring thoracotomy for decortication, drai-
nage of the leakage, reconstruction of the anastomosis or
resection of the necrotic gastric tube. Pulmonary compli-
cations included pneumonia as diagnosed on chest X-ray,
sputum culture or CT scan and postoperative acute respi-
ratory distress syndrome (ARDS). Wound infections were
diagnosed upon positive culture or evident purulent drai-
nage from the surgical wounds. Cardiovascular complica-
tions included atrial fibrillation, infarction or heart failure
as seen on electrocardiogram (ECG), ultrasound and in
laboratory findings. All complications were additionally
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recorded and graded according to the Clavien–Dindo
classification [14].
Patients were examined clinically daily; additional
examinations were performed on indication. If indicated,
examination of the anastomosis consisted of computed
tomography scan with oral contrast and/or endoscopy.
Postoperative monitoring for complications was similar
in all included hospitals, consisting of daily assessment of
clinical parameters. Upon clinical deterioration (i.e., fever,
pain, tachycardia, SIRS and ileus), additional laboratory
assessment and imaging were performed, consisting of CT
scan imaging with oral contrast or endoscopy. Treatment
was initiated immediately upon diagnosis of complications.
Operative technique
Minimally invasive Ivor Lewis esophagectomy starts with
a laparoscopic approach, in which lymphadenectomy of
lymph node stations 1–4, 7–9, 11 and in some centers 12
according to the 10th edition of the JSED classification is
performed [15]. Subsequently, a gastric tube is created, and
a dissection of the lower paraesophageal lymph nodes via
the hiatus could be performed. After changing to prone or
lateral decubitus position, thoracoscopy is performed. In
prone position, double lung ventilation and a pneumotho-
rax of 6–8 mmHg are maintained with insufflation of CO2
with a maximum pressure of 8 mmHg. In left lateral
decubitus position, the right lung is blocked and solely the
left lung is ventilated. A lymphadenectomy is performed of
peri-esophageal, bronchial and subcarinal lymph nodes
(lymph node stations 107–111), depending on the center or
on indication stations 105, 106tbL, and 106recL and
106recR according to the 10th edition of the JSED classi-
fication [16]. The esophagus is divided proximal of the
arcus of the azygos vein, and before or after extraction of
the specimen through a small thoracotomy, an anastomosis
between the proximal esophagus and the gastric tube is
performed [17].
The anastomosis is performed with different methods in
the different participating centers. Some centers perform an
end-to-side anastomosis using a circular stapler of 25 or
28 mm, including the 25-mm Orvil type. Others perform
a side-to-side anastomosis with a linear endostapler and
closure of the defect with a V-Loc suture. In many cases
this is followed by an omental wrap to protect the anas-
tomosis which could reduce the sequelae of an anastomotic
leakage [18]. Differences in the use of anastomotic tech-
nique reflect local expertise and the search for optimal
techniques as described elsewhere [18].
In prone position, the use of a glove adhesive to the
protection ring of the wound or a single port permits
continuity of insufflation during formation of the
anastomosis.
Results
From June 2007 until September 2014, 282 patients in six
different hospitals underwent a total MIE-IL for esopha-
geal cancer. Each participating center performed over 20
esophagectomies per year, with two surgeons performing
the procedure in each center. Pertaining characteristics of
the 282 patients and peri-operative data are presented in
Tables 1 and 2. In total, 90.2 % of patients received
neoadjuvant therapy, usually consisting of chemoradio-
therapy according to the CROSS protocol [6].
The majority of patients (89.0 %) were operated in
prone position. An end-to-side anastomosis was performed
with either a 25-mm stapler in 56.3 % or a 28-mm stapler
in 13.7 % of patients. A side-to-side anastomotic technique
was performed in 29.4 %. An end-to-end hand-sewn
anastomosis was performed in 0.7 %.
Complications
In this cohort, four intraoperative complications were
recorded. In one patient, a lesion of the splenic artery
necessitated a laparoscopic splenectomy. In another
patient, part of the balloon of the selective tracheal tube
migrated into the right bronchus, which had to be removed
by bronchoscopy. In two patients, the operation was
complicated by an aortic lesion, in one patient the stapling
device perforated the aortic arch, the other occurred during
esophageal dissection. In both cases, the operation was
converted to a thoracotomy in prone position, and both
Table 1 Baseline characteristics of patients that underwent mini-
mally invasive Ivor Lewis esophagectomy
Baseline characteristics N (282) %
Gender
Male 218 77.3
Female 64 22.7
Age (mean ± SD) 62.8 ± 8.6
Tumor type 2
Adenocarcinoma 229 81.2
Squamous cell carcinoma 29 10.3
Adenosquamous cell carcinoma 24 8.5
Tumor location (cm) (mean ± SD) 36.2 ± 3.7
Neoadjuvant therapy
None 33 11.3
Chemoradiotherapy 233 82.6
Chemotherapy 16 5.7
Radiotherapy 1 0.4
Frequencies and percentages are depicted for categorical data, and
mean and standard deviations (SD) are depicted for continuous data,
after checking for a normal distribution
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patients had an uncomplicated postoperative recovery.
Conversion to an open procedure, for oncological reasons
or extensive pleural adhesions, occurred in five patients
(1.8 %), no mortality was reported after conversion.
An overview of all postoperative complications is
depicted in Table 3. Median intensive care stay for
uncomplicated patients was 2 days (IQR 1–3 days) and
3 days (IQR 1–9 days) for patients with a complicated
postoperative course (all grades of complications)
(p =\0.001). Average hospital stay for patients with an
uncomplicated postoperative course was 10 days (IQR
8–13 days) as compared to 23 days (IQR 12–41 days) for
patients with a complicated postoperative course
(p =\0.001). Isolated pulmonary complications were
observed in 37 patients (13.1 %), with a median hospital
stay of 14 days (IQR 9.25–17 days).
Anastomotic leakage was observed in 43 patients (15.2 %).
Using the classification proposed by Low et al., grade I
leakage was observed in 6 patients (2.1 %), grade II in 8
patients (2.8 %), grade III in 16 patients (5.7 %) and grade IV
in 13 patients (4.6 %) [13]. Grades and according hospital stay
are depicted in Table 3. Comparison of linear versus circular
stapling techniques depicted no differences in leakage rate,
being 13 versus 14.9 %, respectively (p = 0.710).
Two patients developed a tracheoesophageal fistula
following anastomotic leakage, treated with endoscopic
stents in one patient and a reoperation in order to repair the
fistula in the other patient. No differences were observed in
leak rates between the participating hospitals (p = 0.334).
The effect of was determined using binary logistic
regression analysis. None of the parameters were found to
be predictive for anastomotic leak as depicted in Table 4.
Table 2 Peri-operative data for
minimally invasive Ivor Lewis
esophagectomy
Operative data N (282) %
Type of surgery positioning Minimally invasive Ivor Lewis
esophagectomy
Prone position 251 89.0
Lateral decubitus 31 11.0
Peri-operative blood loss (ml) 242 ± 228
Duration of surgery (min) 333 ± 98
Pathology
T0 58 24.8
T1 48 20.5
T2 31 3.2
T3 94 40.2
T4 3 1.3
N0 140 59.3
N1 48 20.3
N2 34 14.2
N3 14 5.9
Number of lymph nodes 22.9 ± 9.7
R0 resection 185 92.5
Complete regression 30 20.1
Hospital stay [median (IQR)]*
Overall 12 (9–24)
Uncomplicated 10 (8–13)
Complicated 23 (12–41)
ICU stay [median (IQR)]*
Overall 2 (1–5)
Uncomplicated 2 (1–3)
Complicated 3 (1–9)
Complications 123 43.6
Mortality (30-days) 6 2.1
ml milliliters, IQR interquartile range, ICU intensive care unit
* p\ 0.001
** Mann–Whitney U test p values\0.001 regarding hospital/IC stay in uncomplicated versus complicated
cases
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Six (2.1 %) patients died in hospital, or within 30-days
postoperatively, having a Clavien–Dindo grade V compli-
cation. Four patients died after developing multiorgan
failure due to sepsis following pneumonia. One patient died
as a consequence of heart failure. The last patient died
following hemorrhage from a tracheoesophageal fistula.
Pathology
A microscopically radical (R0) resection was obtained in
92.5 % of patients. A complete pathologic response to
neoadjuvant therapy was observed in 20.1 % of patients
after chemoradiotherapy. Average lymph node yield was
22.9 (±9.7) lymph nodes.
Discussion
This multicenter pooled cohort study describes the initial
results of 282 patients with distal esophageal and gas-
troesophageal junction adenocarcinomas, treated with
neoadjuvant therapy, usually chemoradiotherapy, fol-
lowed by a total minimally invasive Ivor Lewis
esophagectomy [12]. The treatment resulted in a radical
resection in[90 % of patients. Although the leakage rate
was relatively high, extensive treatment resulted in a low
combined in-hospital and 30-day mortality rate of 2.1 %,
which is in concordance with other studies [5, 19].
According to these results, MIE-IL can be considered
safe.
Table 3 Postoperative
complications and frequencies
Complications description N (282) % Hospital stay
median (IQR)
Anastomotic leakage 43 15.2
Grade I 6 2.1 25 (18–40)
Grade II 8 2.8 32 (29–92)
Grade III 16 5.7 40 (25–67)
Grade IV 13 4.6 45 (37–65)
Pulmonary complications 37 13.1
Cardiovascular complications 12 4.3
Wound infection 9 3.5
Bronchoesophageal fistula 2
Other (9)
Paraesophageal herniation 3
Bleeding 2
Reoperation for suspected torsion of gastric conduit 1
Reoperation for suspected anastomotic leakage 1
Leakage of staple line stomach 1
Iatrogenic lesion of spleen 1
For the different grades of anastomotic leakage, the median (IQR) hospital stay is depicted, hospital stay
increases with increasing grades of anastomotic leak, with Kruskal–Wallis one-way ANOVA for k samples
p\ 0.001
Table 4 Binary logistic
regression analysis for effect of
anastomotic technique, duration
of surgery, neoadjuvant therapy
and clinical T stage on the
occurrence of anastomotic leak
Parameter B Sig. Exp(B) 95 % C.I. for EXP(B)
Lower Upper
Hospital .216
Clinical T stage -.512 .350 .599 .205 1.753
Neoadjuvant treatment (yes/no) -.199 .866 .820 .081 8.281
Duration of surgery (min) -.004 .402 .996 .987 1.005
Anastomosis (linear/circular) -2.482 .120 .084 .004 1.916
Constant 1.126 .591 3.083
p value of overall model being p = 0.104
Surg Endosc (2017) 31:119–126 123
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Previous studies have favored cervical anastomosis,
reporting that cervical leakage was manageable with a
cervical enterocutaneous fistula, with less morbidity and
mortality compared to leakage following thoracic anasto-
mosis [20]. There is evidence that cervical anastomoses are
associated with a higher anastomotic leakage rate, more
stenosis and more recurrent laryngeal nerve lesions,
although available randomized evidence is limited [4]. A
recent study showed comparable morbidity and mortality
rates following cervical or thoracic anastomosis [21].
Differences in anastomotic leak rate may be explained by a
shorter gastric tube segment in MIE-IL, possibly holding
for better vascularization at the site of anastomosis [22].
Although our main conclusion is that MIE-IL can be
considered safe, several observations should be addressed.
Overall anastomotic leakage was observed in 15.2 % of
patients. However, the incidence of the higher grades was
relatively low. The overall leakage rate observed in this
study is in concordance with the available literature [19,
23–25]. Previous studies described an empyema rate of
5 %, an anastomotic leakage requiring surgery in 4 % of
patients and a gastric tube necrosis in 2 % of patients [25].
No statistically significant differences in anastomotic
leak rate were observed for the five different techniques
used in this cohort, although it should be noted some
techniques were not applied often, and statistical power for
comparison of these techniques is low. Here, the general
principles of anastomosis such as tension- and rotation-
free, patency and optimal perfusion are essential. Intraop-
erative evaluation of the anastomosis may be performed
with methylene blue or endoscopy, but evidence has not
been obtained in a systematic manner. The use of omen-
toplasty covering the anastomosis resulted in less postop-
erative anastomotic leakage after esophagectomy in a
Cochrane study, but the outcome after transthoracic anas-
tomosis was just not found significant probably because of
the low number of studies including this type of anasto-
mosis [26].
Regression analysis determined that anastomotic tech-
nique, duration of surgery, neoadjuvant therapy and clini-
cal T stage were not predictive for anastomotic leak.
Further emphasizing different techniques may be consid-
ered safe, depending on local expertise.
Pulmonary complications were observed in 13.3 %,
similar to the results observed in the TIME-trial, in which
pulmonary complications were observed in 12 % of
patients in the minimally invasive group and 34 % in
patients operated in the open group [5]. Interestingly, most
patients in this series were operated in prone position,
whereas previous series have mainly operated in lateral
decubitus position [19, 25]. In the lateral approach, using
selective intubation, a lung block is applied during the
whole operation, whereas in prone position lung block is
not necessary at all. Thoracoscopic surgery in prone posi-
tion has shown to allow for earlier mobilization and less
respiratory complications [27].
No recurrent nerve lesions were observed here in the
present cohort. Previous studies displayed similar results
with recurrent nerve lesions in 8 % of patients with cer-
vical anastomosis and 1 % of patients with intrathoracic
anastomosis [25].
Overall hospital stay and intensive care (ICU) stay were
longer following postoperative complications, with an ICU
stay of a median of 2 and 3 days and a median of 10 and
23 days for uncomplicated and complicated hospital stay,
respectively. These results are in concordance with the
literature stating average stays of 2 days for ICU and
7 days for hospital stay [25].
Indications for MIE-IL vary. Some surgeons use this
approach for treating gastroesophageal junction tumors
only, whereas other surgeons claim that for treating distal
esophageal tumors, a safe resection can be performed with
a margin of 5 cm and adequate subcarinal and paratracheal
lymphadenectomy, thereby making this approach suit-
able for tumors located up to 5-cm distal of the carina [19,
28, 29].
Over ninety percent of patients in this cohort received
neoadjuvant therapy, usually consisting of chemoradio-
therapy [6]. In previous series of MIE-IL, only 29 % of
patients received neoadjuvant therapy [25]. It has been
stated that chemoradiotherapy might affect anastomotic
healing [30]. Two series reported anastomotic complica-
tions in 6.7 and 13 % of patients that received chemora-
diotherapy followed by IL esophagectomy [30, 31].
Multivariable analysis found that the preoperative radiation
dose received on the fundus of the stomach was associated
with anastomotic complications. The radiation dose
received by the proximal esophagus was not associated
with anastomotic complications following IL [30].
In the CROSS study, no differences were found in
predominantly cervical anastomotic leakage rates between
patients that received neoadjuvant chemoradiotherapy
versus patients that received no neoadjuvant therapy [6].
In conclusion, considering the increase in distal adeno-
carcinomas in the West and possible benefits on postop-
erative morbidity, the advantages of a two-stage procedure
should be recognized: a shorter gastric tube segment
accounting for better vascularization of the anastomosis,
less recurrent nerve injuries and less stenosis compared to
cervical anastomosis. Long-term oncological safety is to be
determined in follow-up studies. Future research should
address implementation problems, such as standardization
of operative techniques and type of anastomosis. Accord-
ing to the IDEAL framework, this procedure is moving
from the Development to the Exploration stage. The fol-
lowing stage will encompass a consensus in order to select
124 Surg Endosc (2017) 31:119–126
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the best (two) procedure (s) in order to perform a ran-
domized controlled trial [32]. The primary goal of the
study will be to decrease all postoperative complications,
while maintaining optimal quality of surgical oncological
resection.
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